Cargando…
Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice
SIMPLE SUMMARY: Cancer cachexia is a highly debilitating syndrome involving severe body weight loss. Worldwide around 9–14.5 million cancer patients suffer from cachexia every year and many of them die because of cachexia. Our study aimed to assess the possible role of apelin against muscle loss dur...
Autores principales: | Re Cecconi, Andrea David, Barone, Mara, Forti, Mara, Lunardi, Martina, Cagnotto, Alfredo, Salmona, Mario, Olivari, Davide, Zentilin, Lorena, Resovi, Andrea, Persichitti, Perla, Belotti, Dorina, Palo, Federica, Takakura, Nobuyuki, Kidoya, Hiroyasu, Piccirillo, Rosanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997437/ https://www.ncbi.nlm.nih.gov/pubmed/35406586 http://dx.doi.org/10.3390/cancers14071814 |
Ejemplares similares
-
Musclin, A Myokine Induced by Aerobic Exercise, Retards Muscle Atrophy During Cancer Cachexia in Mice
por: Re Cecconi, Andrea D., et al.
Publicado: (2019) -
Endothelial cell-derived Apelin inhibits tumor growth by altering immune cell localization
por: Hu, Liuying, et al.
Publicado: (2021) -
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics
por: Balsano, Rita, et al.
Publicado: (2022) -
Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy
por: Zhang, Li, et al.
Publicado: (2015) -
Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)